Comparing proportional hazards and accelerated failure time models: an application in influenza

被引:59
作者
Patel, Katie [1 ]
Kay, Richard [1 ]
Rowell, Lucy [1 ]
机构
[1] Roche Prod Ltd, Welwyn Garden City AL7 1TW, Herts, England
关键词
accelerated failure time model; proportional hazards model; influenza; time-to-event data;
D O I
10.1002/pst.213
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The proportional hazards (PH) model is routinely employed for the analysis of time-to-event data in medical research when it is required to assess the effect of an intervention in the presence of covariates. The assumption of PH required for the PH approach may not hold, especially in circumstances where the effect of the intervention is to delay or accelerate the onset of an event rather than to reduce or increase the overall proportion of subjects who observe the event through time. If the assumption of PH is violated, the results from a PH model will be difficult to generalize to situations where the length of follow-up is different to that used in the analysis. It is also difficult to translate the results into the effect upon the expected median duration of illness for a patient in a clinical setting. The accelerated failure time (AFT) approach is an alternative strategy for the analysis of time-to-event data and can be suitable even when hazards are not proportional and this family of models contains a certain form of PH as a special case. The framework can allow for different forms of the hazard function and may provide a closer description of the data in certain circumstances. In addition, the results of the AFT model may be easier to interpret and more relevant to clinicians, as they can be directly translated into expected reduction or prolongation of the median time to event, unlike the hazard ratio. We recommend that consideration is given to an AFT modelling approach in the analysis of time-to-event data in medical research. Copyright (C) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:213 / 224
页数:12
相关论文
共 14 条
  • [1] Allison PD., 2010, SURVIVAL ANAL USING
  • [2] Survival Analysis Part II: Multivariate data analysis - an introduction to concepts and methods
    Bradburn, MJ
    Clark, TG
    Love, SB
    Altman, DG
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (03) : 431 - 436
  • [3] Survival Analysis Part III: Multivariate data analysis - choosing a model and assessing its adequacy and fit
    Bradburn, MJ
    Clark, TG
    Love, SB
    Altman, DG
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (04) : 605 - 611
  • [4] Survival analysis part I: Basic concepts and first analyses
    Clark, TG
    Bradburn, MJ
    Love, SB
    Altman, DG
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (02) : 232 - 238
  • [5] COLLETT D, 2003, MODELLING SURVIVAL
  • [6] COX DR, 1972, J R STAT SOC B, V34, P187
  • [7] An explanation of the hazard ratio
    Kay, R
    [J]. PHARMACEUTICAL STATISTICS, 2004, 3 (04) : 295 - 297
  • [8] Kay R, 2002, DRUG INF J, V36, P571, DOI 10.1177/009286150203600312
  • [9] Alternatives to the hazard ratio in summarizing efficacy in time-to-event studies: an example from influenza trials
    Keene, ON
    [J]. STATISTICS IN MEDICINE, 2002, 21 (23) : 3687 - 3700
  • [10] Choice of parametric models in survival analysis: applications to monotherapy for epilepsy and cerebral palsy
    Kwong, GPS
    Hutton, JL
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2003, 52 : 153 - 168